Headache Pain Model Enough To Show AAC Combination’s Efficacy – BMS
This article was originally published in The Tan Sheet
Studying the efficacy of 500 mg aspirin/500 mg acetaminophen/130 mg caffeine in a tension headache pain model is sufficient to demonstrate the combination merits Category I status in the internal analgesic drug products tentative final monograph, according to Bristol-Myers Squibb
You may also be interested in...
An acetaminophen-only treatment arm in Bristol-Myers Squibb's planned clinical study on the efficacy of different caffeine doses in analgesic adjuvancy is unnecessary, FDA says in a recent letter
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
Perrigo promotes in pricing, planning